Role of intestinal serotonin transporter in post traumatic stress disorder
Role of intestinal serotonin transporter in post traumatic stress disorder
批准号:
10590033
负责人:
Ravinder K Gill
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2024
资助国家:
美国
项目状态:
未结题
起止时间:
2024-04-01 至 2028-03-31
关键词:
AffectAgeAggressive behaviorAllelesAmygdaloid structureAnimal ModelAnxietyAnxiety DisordersBacteriaBehaviorBiological AssayBrainBrain-Derived Neurotrophic FactorCCL2 geneCXCL1 geneCellsChronicDataDesulfovibrioDevelopmentDisease ManagementDisease modelEnteralEpithelial CellsEpitheliumExhibitsFDA approvedFemaleFrightFunctional disorderGenesGenetic PolymorphismGenetic studyHealthHippocampusHormonesHuman GeneticsImpulsive BehaviorIndividualIntestinesKnock-inLaboratoriesLinkMeasuresMedicalMental DepressionMental disordersMicrobeModelingMolecularMood DisordersMorbidity - disease rateMusNeuronsNeurotransmittersOccupationalOutcome StudyOxidoreductasePathway interactionsPatientsPharmaceutical PreparationsPharmacotherapyPhenotypePlayPost-Traumatic Stress DisordersPre-Clinical ModelPredispositionRegulatory PathwayRoleSelective Serotonin Reuptake InhibitorSerotoninServicesSex DifferencesSocial isolationStressStructureSulfateTissuesTransgenic ModelTraumaTreatment outcomeTryptophan 5-monooxygenaseVeteransantimicrobial peptidebench to bedsideconditioned feardisabilitydisability paymenteffective therapyextracellularfecal transplantationgastrointestinal epitheliumgut bacteriagut microbesgut microbiotagut-brain axisileuminsightintestinal epitheliumliquid chromatography mass spectrometrymalemicrobialmicrobial based therapymicrobiotamicrobiota-gut-brain axismind controlmouse modelneuroinflammationnovelnovel therapeuticsoverexpressionresilienceresponsereuptakeserotonin receptorserotonin transportersevere mental illnesssexsingle-cell RNA sequencingsocialstress related disorderstressorsuicidal behaviorsulfate reducing bacteriatranscriptometraumatic stress
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Post traumatic stress disorder (PTSD) a devastating psychiatric disorder and one of the most difficult service-
related disabilities in Veterans, nonetheless without a consistently effective therapy. The only FDA-approved
drugs for the treatment of PTSD are the selective serotonin reuptake inhibitors (SSRIs); the response rate to
these drugs, however, is relatively small requiring development of more specific and individually effective
therapies. In this regard, the neurotransmitter and hormone, serotonin (5-HT) is well-recognized for its role in
depression, anxiety, aggression, impulsivity, and suicidal behaviors, which are frequently found in PTSD
patients. Serotonin transporter, (SERT; SLC6A4), regulates the extracellular availability of 5-HT, and is a
common target for SSRIs. Linkage of the short allele of the SERT gene polymorphism has been implicated in
increasing the vulnerability to develop PTSD and predicting poor treatment outcome. In this regard, SERT is
abundantly expressed in the gut and its dysfunction has been shown to cause gut microbiota alterations; albeit
its role in the predisposition or progression of PTSD is not fully understood. To gain insights into the role of gut-
microbiota and SERT interactions in PTSD, we utilized our recently developed novel transgenic model with
inducible overexpression of SERT restricted to intestinal epithelial cells (SOEIEC) that exhibits low fecal 5-HT
levels (LC/MS). The mouse model of protracted social isolation (SI), was used as chronic stressor important to
elicit PTSD-like increased aggression in resident intruder assays. Interestingly, males with SOEIEC under SI
exhibited increase in aggression while females were resilient as compared to wild type counterparts. To
understand the sex-dependent differences, we correlated the aggression with structure of gut microbial
communities. The data demonstrated a strong negative association of aggression with genus Desulfovibrio
(sulfate reducing bacteria) and positive associations with Bacteroidales, Gastranaerophilales, and genus-
Anaerotruncus. How 5-HT pools in the gut impact upstream factors affecting gut microbiota and triggers
downstream factors in the gut and brain leading to PTSD like behavior in a sex-dependent manner is not known.
Thus, our proposed studies will use cell specific SOE (in IEC and in neurons) to further elucidate PTSD related
fear conditioning responses and aggression behavior and elucidate the underlying molecular mechanisms
across gut-brain axis (Aim 1). Additional studies utilizing SOE and SERT KO are needed to assess the causal
role of SERT induced gut-microbiota changes in predisposing mice (M/F) to fear deficits/increased aggression
(Aim 2). This will be achieved by fecal microbial transplant and assessing the functional role of gut microbial
changes by integrating the PTSD-like behavior with downstream targets (single cell RNA seq) and selected
metabolites along gut-brain axis. The outcome of the studies will provide novel insights into the role of intestinal
SERT in PTSD predisposition and will pave the way for microbial based therapeutics for PTSD management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intestinal 5-HT Transporter: A novel therapeutic target for GI disorders
-
批准号:8629924
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2014
-
负责人:Ravinder K Gill
-
依托单位:
Intestinal 5-HT Transporter: A novel therapeutic target for GI disorders
-
批准号:10316170
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2014
-
负责人:Ravinder K Gill
-
依托单位:
Intestinal 5-HT Transporter: A novel therapeutic target for GI disorder
-
批准号:10361310
-
项目类别:
-
资助金额:$3.26万
-
财政年份:2014
-
负责人:Ravinder K Gill
-
依托单位:
Mechanisms of Inhibition of Intestinal SERT by EPEC Infection.
-
批准号:8487402
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2012
-
负责人:Ravinder K Gill
-
依托单位:
Mechanisms of Inhibition of Intestinal SERT by EPEC Infection.
-
批准号:8356809
-
项目类别:
-
资助金额:$6.3万
-
财政年份:2012
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7078067
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7671351
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7921606
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7805000
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7483111
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:8128440
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: